MetLife Investment Management, LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 80 filers reported holding UROGEN PHARMA LTD in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$145,746
+35.4%
10,4030.0%0.00%0.0%
Q2 2023$107,671
-13.0%
10,403
+41.5%
0.00%0.0%
Q3 2021$123,694
-26.6%
7,354
-15.0%
0.00%
-50.0%
Q1 2021$168,580
-12.5%
8,654
-13.4%
0.00%0.0%
Q3 2020$192,707
-26.1%
9,9900.0%0.00%
-33.3%
Q2 2020$260,939
-21.7%
9,9900.0%0.00%0.0%
Q4 2019$333,3669,9900.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders